Bob Silverman

Bob Silverman

Consultant / Adviseur bij
The New York City Investment Fund Manager, Inc.
Finance
Consumer Services
Commercial Services

Profiel

Bob A. Silverman currently works at The New York City Investment Fund Manager, Inc., as Advisor and C2i Genomics, Inc., as Chief Business Officer from 2023.
Mr. Silverman also formerly worked at Biohealth Innovation, Inc., as Director, Roche Holding AG, as Venture Capital Lead from 2012 to 2020, Pennie & Edmonds LLP, as Associate, Alloy Therapeutics LLC, as Executive Partner & Chief Business Officer from 2019 to 2021, and Rejuveron Life Sciences AG, as Chief Business Officer from 2021 to 2022.
Mr. Silverman received his undergraduate degree from Franklin & Marshall College and graduate degree from Boston University School of Law.

Actieve functies van Bob Silverman

BedrijvenFunctieBegin
Consultant / Adviseur -
Corporate Officer/Principal 01-01-2023

Eerdere bekende functies van Bob Silverman

BedrijvenFunctieEinde
Corporate Officer/Principal 01-12-2022
Corporate Officer/Principal 01-07-2021
ROCHE HOLDING AG Algemeen Adviseur 31-12-2003
Corporate Officer/Principal 31-12-1993
Directeur/Bestuurslid -
Ervaring van Bob Silverman in detail bekijken

Opleiding van Bob Silverman

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

63

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit9

Health Technology

Commercial Services

Consumer Services

Finance

Consumer Services

Finance

Commercial Services

Technology Services

Finance

  1. Beurs
  2. Insiders
  3. Bob Silverman